Lack of clinically relevant interactions between bictegravir and metformin in persons with diabetes and HIV

J Antimicrob Chemother. 2021 Jun 18;76(7):1945-1946. doi: 10.1093/jac/dkab077.

Authors

Dario Cattaneo^{1

2}, Tiziana Formenti³, Davide Minisci³, Giacomo Casalini³, Paola Meraviglia³, Cristina Gervasoni^{2

3}

Affiliations

¹ Unit of Clinical Pharmacology, Fatebenefratelli Sacco University Hospital, Milan, Italy.
² Gestione Ambulatoriale Politerapie (GAP) outpatient clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
³ 3rd Division of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.

PMID: 33729482
DOI: 10.1093/jac/dkab077

No abstract available

Publication types

Letter

MeSH terms

Amides
Diabetes Mellitus*
HIV Infections* / complications
HIV Infections* / drug therapy
Heterocyclic Compounds, 3-Ring
Heterocyclic Compounds, 4 or More Rings
Humans
Metformin* / therapeutic use
Piperazines
Pyridones

Substances

Amides
Heterocyclic Compounds, 3-Ring
Heterocyclic Compounds, 4 or More Rings
Piperazines
Pyridones
bictegravir
Metformin